If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Five government agencies now require special export licenses for three newly restricted compounds, according to an official announcement on...

President Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

China and the United States have agreed to reduce tariffs on certain goods. This move aims to boost trade between the two nations, particul...

Tamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...

Indian pharmaceutical exports reached over $31 billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United...

London’s FTSE 100 edged lower as losses in energy majors and AstraZeneca weighed on the index amid thin holiday trading. Weak crude prices ...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

India and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...

Sun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...

Regeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...

New US tariffs on patented drugs will not significantly impact India. The country mainly exports affordable generic medicines to America. T...

President Donald Trump has signed an executive order introducing significant pharmaceutical tariffs. Companies failing to strike pricing de...

America is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...

US President Trump had earlier suggested pharmaceutical tariffs could reach 200% after a year, incentivizing domestic manufacturing. On Tue...